Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | YTHDF3 | Q7Z739 | 1/20 | 0.35 |
| ▸ | YTHDF1 | Q9BYJ9 | 1/20 | 0.35 |
| ▸ | YTHDF2 | Q9Y5A9 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6435895 | 0.71 | CA1 (0.56) | ALDH1A1LMNACYP1A2CA1YTHDF3 | |
| SCHEMBL9354003 | 0.65 | CA1 (0.43) | ALDH1A1LMNACYP1A2CA1YTHDF3 | |
| SCHEMBL1774205 | 0.62 | — | — | |
| SCHEMBL30960885 | 0.60 | FLT3 (0.44) | ALDH1A1LMNACYP1A2SMN1; SMN2HSD17B10 | |
| SCHEMBL11841644 | 0.60 | CYP1A2 (0.71) | ALDH1A1LMNACYP1A2CA1YTHDF3 | |
| Hydrochloric Acid SCHEMBL4663528 | 0.59 | CA1 (0.46) | ALDH1A1LMNACYP1A2CA1YTHDF3 | |
| Orotic Acid SCHEMBL20865 | 0.58 | ALDH1A1 (1.00) | ALDH1A1LMNACYP1A2CA1SMN1; SMN2 | |
| SCHEMBL8974784 | 0.58 | GPR84 (0.50) | ALDH1A1LMNASMN1; SMN2GPR84KDM4C | |
| SCHEMBL27661275 | 0.58 | ALDH1A1 (0.45) | ALDH1A1LMNACYP1A2CA1YTHDF3 | |
| Orotic Acid SCHEMBL29394966 | 0.58 | ALDH1A1 (1.00) | ALDH1A1LMNACYP1A2CA1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170327471-A1 | Aryl sulphide and aryl sulphoxide derivatives having C-C-attached uracils as pesticides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-11-16 | — | — | US | disclosed |
| EP-3191458-A1 | ARYL SULFIDE AND ARYL SULFOXIDE DERIVATIVES HAVING C-C LINKED URACILS, AS PEST CONTROL AGENTS | Bayer CropScience AG (DE) | 2017-07-19 | — | — | EP | disclosed |
| WO-2016037997-A1 | ARYL SULFIDE AND ARYL SULFOXIDE DERIVATIVES HAVING C-C LINKED URACILS, AS PEST CONTROL AGENTS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170327471-A1 | Aryl sulphide and aryl sulphoxide derivatives having C-C-attached uracils as pesticides | DDT, ARSA, USP21 | ALDH1A1 279/4885LMNA 4014/4885CYP1A2 423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.